Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: Placebo; Drug: Non-steroidal anti-inflammatory drugs (NSAIDs); Drug: methotrexate; Drug: corticosteroids
Sponsor: Hoffmann-La Roche
Active, not recruiting - verified July 2011
